tipifarnib has been researched along with methylnitrosourea in 2 studies
| Studies (tipifarnib) | Trials (tipifarnib) | Recent Studies (post-2010) (tipifarnib) | Studies (methylnitrosourea) | Trials (methylnitrosourea) | Recent Studies (post-2010) (methylnitrosourea) |
|---|---|---|---|---|---|
| 309 | 92 | 94 | 3,242 | 10 | 346 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| End, DW; Grubbs, CJ; Lemon, WJ; Lu, Y; Lubet, RA; Wang, Y; Yao, R; You, M | 1 |
| Christov, K; End, DW; Grubbs, CJ; Juliana, MM; Lubet, RA; Steele, VE; Yao, R; You, M | 1 |
2 other study(ies) available for tipifarnib and methylnitrosourea
| Article | Year |
|---|---|
Efficacy of the farnesyltransferase inhibitor R115777 in a rat mammary tumor model: role of Ha-ras mutations and use of microarray analysis in identifying potential targets.
Topics: Alkylating Agents; Animals; Farnesyltranstransferase; Female; Gene Expression; Genes, ras; Mammary Neoplasms, Experimental; Methylnitrosourea; Mutation; Oligonucleotide Array Sequence Analysis; Quinolones; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction | 2006 |
Effects of the farnesyl transferase inhibitor R115777 (Zarnestra) on mammary carcinogenesis: prevention, therapy, and role of HaRas mutations.
Topics: Animals; Anticarcinogenic Agents; Antimutagenic Agents; Apoptosis; Carcinogens; Cell Division; Enzyme Inhibitors; Farnesyltranstransferase; Female; Genes, ras; Mammary Neoplasms, Experimental; Methylnitrosourea; Quinolones; Rats; Rats, Sprague-Dawley | 2006 |